Methods for diagnosing, monitoring and controlling the onset and

Details Methods for diagnosing, monitoring and controlling the onset and Methods for diagnosing, monitoring and controlling the onset and

1990-07-25

1991-04-02

Page, Thurman

Drug, bio-affecting and body treating compositions

Inorganic active ingredient containing

Aluminum, calcium or magnesium element, or compound containing

424439, 424697, 423635, A61K 3306, A61K 3310, C01F 502, C01F 540

Patent

active

050046152

ABSTRACT:
Methods for diagnosing, monitoring and controlling the onset and progression of certain dementias, such as AD. The onset and progression of dementia are diagnosed and monitored by following changes in the relative concentrations of two forms of albumin in either serum or CSF. The onset and progression of dementia are controlled and memory loss is impeded or the impairment of memory is improved by dietary supplementation or the administration of Mg.

REFERENCES:
patent: 4837164 (1989-06-01), Glick

Affiliated with

Also associated with

Rating

Methods for diagnosing, monitoring and controlling the onset and does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for diagnosing, monitoring and controlling the onset and, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for diagnosing, monitoring and controlling the onset and will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-326108